G. Kirtschig et al., ACQUIRED SUBEPIDERMAL BULLOUS DISEASES ASSOCIATED WITH PSORIASIS - A CLINICAL, IMMUNOPATHOLOGICAL AND IMMUNOGENETIC STUDY, British journal of dermatology, 135(5), 1996, pp. 738-745
Clinical, immunopathological and immunogenetic studies of four patient
s with a subepidermal bullous disease associated with psoriasis were c
arried out td determine the true nature of the blistering disease and
to investigate further the relationship between psoriasis and acquired
subepidermal bullous diseases, Autoantibodies in all four patients bo
und to the epidermal side of salt-split skin by indirect immunofluores
cence and detected the major bullous pemphigoid (BP) antigens by immun
oblotting, One had additional IgA autoantibodies binding an epidermal
polypeptide of 270/280 kDa and another had circulating IgG autoantibod
ies which detected both BP and epidermolysis bullosa acquisita (EBA) a
ntigens. All patients had active psoriasis at the onset of the bullous
disease, Three patients were being treated with tar when blisters dev
eloped: one patient also received UVB radiation and experienced a rela
pse after exposure to sunlight, HI,A phenotypes in three patients were
determined. All the patients responded well to methotrexate, These fi
ndings demonstrate that BP is the subepidermal bullous disease most as
sociated with psoriasis, Changes at the basement membrane zone in psor
iasis may be responsible for the heterogeneous antibody response and m
ay trigger the bullous disease, as may antipsoriatic treatment includi
ng tar and UV radiation, However, common immunogenetic mechanisms may
play a crucial part in this disease association.